↓ Skip to main content

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
5 news outlets
twitter
5 X users

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
77 Mendeley